Tyenne
RxNorm concept 2679433, brand name (bn).
- RxCUI
- 2679433
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2679433 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- tocilizumab-aazg (PIN, has precise ingredient)
- tocilizumab-aazg 20 MG/ML [Tyenne] (SBDC, ingredient of)
- Tyenne Injectable Product (SBDG, ingredient of)
- tocilizumab Injection [Tyenne] (SBDF, ingredient of)
- 4 ML tocilizumab-aazg 20 MG/ML Injection [Tyenne] (SBD, ingredient of)
- 10 ML tocilizumab-aazg 20 MG/ML Injection [Tyenne] (SBD, ingredient of)
- 20 ML tocilizumab-aazg 20 MG/ML Injection [Tyenne] (SBD, ingredient of)
- tocilizumab-aazg 180 MG/ML [Tyenne] (SBDC, ingredient of)
- tocilizumab Auto-Injector [Tyenne] (SBDF, ingredient of)
- 0.9 ML tocilizumab-aazg 180 MG/ML Auto-Injector [Tyenne] (SBD, ingredient of)
- tocilizumab Prefilled Syringe [Tyenne] (SBDF, ingredient of)
- 0.9 ML tocilizumab-aazg 180 MG/ML Prefilled Syringe [Tyenne] (SBD, ingredient of)
- tocilizumab (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2679433 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2679433 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2679433. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.